首页 / 词典 / good

hbig

  • 网络乙肝免疫球蛋白;乙型肝炎免疫球蛋白;免疫球蛋白
hbighbig
  1. Combining immunoprophylaxis , including HBIG and hepatitis B vaccine .

    新生儿免疫预防主张乙肝免疫球蛋白与乙肝疫苗联合应用。

  2. A randomized double blind control study on preventive effect of mother and infant vertical transmission to hepatitis B by HBIG

    乙肝免疫球蛋白预防乙肝母婴垂直传播随机双盲对照研究

  3. Clinical Study on the Interruptive Effect of HBV Intrauterine Transmission by Early Using of HBIG

    早孕期使用HBIG阻断HBV宫内传播的临床研究

  4. CONCLUSIONS : The HBV intrauterine infection could be decreased by using HBIG during pregnancy .

    结论:产前应用HBIG可降低乙肝病毒宫内感染率。

  5. Meta-analysis on the effect of HBIG on blocking HBV intrauterine transmission

    HBIG阻断乙肝母婴传播疗效的Meta分析

  6. Efficacy of intramuscular HBIg in preventing hepatitis B virus reinfection after liver transplantation

    肌注型HBIg预防肝移植术后乙肝病毒再感染的疗效分析

  7. HBsAg and anti-HBs simultaneously positive when the treatment was failed with HBIG .

    应用HBIG治疗失败时可以出现HBsAg与抗-HBs同时阳性。

  8. Hepatitis B immunoglobulin ( HBIG ) was injected during the pregnancy ;

    孕期全程进行接种乙肝免疫球蛋白(HBIG);

  9. Conclusion : HBIG can prevent the mother and infant transmission effectively , reduces the HBV infection rate .

    结论HBIG能有效预防母婴传播,减少HBV感染率。

  10. Effect of HBIG on blocking mo the r - to - infant transmission of HBV

    HBIG阻断乙型肝炎病毒母婴传播

  11. Sequence analysis on HBV DNA " a " determinant mutation in children failed in HBIG vaccination

    免疫失败儿童乙肝病毒S基因a抗原决定簇序列分析

  12. The placenta HBV infection rate can be reduced by HBIG passive immunization of pregnant women .

    注射HBIG可降低胎盘HBV感染率。

  13. HBIg and Lamivudine in Prevention of HBV Recurrence after Liver Transplantation : A Systematic Review

    拉米夫定与乙肝免疫球蛋白(HBIg)合用防治乙肝相关性肝病肝移植后乙肝复发的系统评价

  14. HBIG does not improve the long term immune efficacy of the YHB vaccine .

    联合使用HBIG并不增加基因疫苗的长期免疫效果。

  15. The result of the prevention of maternal-infant transmission by HBIG and HB vaccine in Beijing district

    北京地区使用HBIG和乙型肝炎疫苗联合阻断母婴传播的效果观察

  16. The use of lamivudine and HBIg should be individualized .

    拉米夫定和HBIg用药应实现个体化。

  17. Some groups of certain concentration of HBIG can protect morphology of JAR cells infected by HBV close to normal .

    一定浓度的HBIG保护HBV感染的JAR细胞形态接近正常。

  18. The groups of Low concentration of HBIG can not enhance HBV infect JAR cells in vitro . 4 .

    较低浓度的HBIG不能增强乙型肝炎病毒感染体外培养的JAR细胞。

  19. Observation of Effect of Hapatitis B Vaccine Single Use and Combination Use with HBIG in Blocking HBV Mother-infant Transmission

    乙肝疫苗与乙肝免疫球蛋白联用阻断HBV母婴传播

  20. HBIG preventive effect to pregnant woman carrying pure HBsAg is surpass both HBsAg , HBeAg .

    HBIG对单纯HBsAg孕妇预防效果优于HBsAg、HBeAg双阳性孕妇。

  21. Investigation on relationship between HBIG injection of pregnant women with positive HBsAg and intrauterine infection of HBV in Taiyuan

    太原市HBsAg阳性孕妇注射HBIG与HBV宫内感染关系的研究

  22. HBIG injection during third trimester can reduce the maternal HBV-DNA replication in vivo volume . 5 .

    孕晚期注射HBIG能降低乙肝病毒携带孕妇体内的病毒复制量。

  23. Conclusions Combination of intramuscular HBIg and Lamivudine as prophylaxis of HBV reinfection is effective .

    结论拉米夫定联合肌肉注射剂型的人乙型肝炎免疫球蛋白可有效预防肝移植术后HBV再感染;

  24. Analysis of correlation factors of intrauterine interruption failure for HBV infected pregnant women using HBIG during in the last trimester of pregnancy

    乙型肝炎病毒感染孕妇孕晚期HBIG宫内阻断失败相关因素分析

  25. In Lamivudine + HBIG group , 3 recipients had HBV recurrence ( 6.7 % ) .

    联合用药组45例患者有3例乙肝复发,复发率为6.7%(3/45),未检测到YMDD变异株。

  26. Influence on serum hepatitis B virus transcripts in newborns by HBIG immuno-blocking therapy during the later stage of pregnancy

    妊娠晚期抗病毒免疫阻断治疗对新生儿血清HBV转录体的影响

  27. The Effect Assay of HBIG and HB Vaccine Used on the Interruptive Mother-to-baby Transmission of HB

    HBIG及乙肝疫苗联合应用阻断乙肝母婴传播效果分析

  28. The Observation of Clinical Effect of Passive Immunization of HBIG Blocking the Hepatitis B Virus to the Maternal-Infantile Transimission Action

    HBIG阻断乙肝病毒母婴传播的临床疗效观察

  29. Objective To evaluate the efficacy of combination of intramuscular HBIg and nucleoside analogs of HBV reinfection .

    目的评价小剂量肌肉注射剂型乙肝免疫球蛋白(HBIg)联合核苷类抗病毒药物预防肝移植术后乙肝病毒(HBV)再感染的疗效。

  30. Conclusion Combination of intramuscular HBIg and nucleoside analogs as prophylaxis of HBV reinfection is effective .

    结论肌注型HBIg联合核苷类抗病毒药物能有效预防肝移植术后HBV再感染。